Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
2(11%)
Results Posted
15%(2 trials)

Phase Distribution

Ph phase_2
2
11%
Ph phase_1
3
17%
Ph phase_4
5
28%
Ph phase_3
5
28%
Ph not_applicable
3
17%

Phase Distribution

3

Early Stage

2

Mid Stage

10

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
3(16.7%)
Phase 2Efficacy & side effects
2(11.1%)
Phase 3Large-scale testing
5(27.8%)
Phase 4Post-market surveillance
5(27.8%)
N/ANon-phased studies
3(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.9%

13 of 14 finished

Non-Completion Rate

7.1%

1 ended early

Currently Active

2

trials recruiting

Total Trials

18

all time

Status Distribution
Active(3)
Completed(13)
Terminated(1)
Other(1)

Detailed Status

Completed13
Recruiting2
unknown1
Enrolling by invitation1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (16.7%)
Phase 22 (11.1%)
Phase 35 (27.8%)
Phase 45 (27.8%)
N/A3 (16.7%)

Trials by Status

unknown16%
completed1372%
enrolling_by_invitation16%
withdrawn16%
recruiting211%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT06335160Not Applicable

Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine

Recruiting
NCT06736691Phase 3

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

Enrolling By Invitation
NCT06720259Phase 2

Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura

Completed
NCT01837862Phase 1

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

Completed
NCT02644291Phase 1

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Completed
NCT04443049Not Applicable

To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.

Unknown
NCT01729260Phase 1

Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide

Completed
NCT03995680Phase 2

Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm

Completed
NCT03925662Phase 3

Mebendazole as Adjuvant Treatment for Colon Cancer

Recruiting
NCT03278431Phase 4

Triple Combinations Against Hookworm Infections in Lao

Completed
NCT03261596Phase 4

Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana

Withdrawn
NCT02034162Phase 3

A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric Participants

Completed
NCT02385058Phase 4

Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population

Completed
NCT01379326Phase 4

Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2

Completed
NCT01314937Phase 4

The Effect of a Deworming Intervention to Improve Early Childhood Growth and Development in Resource-poor Areas

Completed
NCT01173562Phase 3

A Safety Study of Mebendazole in Children 2 to 10 Years of Age

Completed
NCT00116493Phase 3

Severe Anemia Treatment Trials, Pakistan

Completed
NCT01050452Not Applicable

Safety and Efficacy of Drug Combinations Against Trichuris Trichiura

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18